News & Events
Check out the latest in all things Cas-CLOVER and piggyBac with their implications, applications, and advantages in the real world.
NorthX Biologics and Demeetra announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full ...
Demeetra today announced the renewal of Taiho Pharmaceutical's research license for its piggyBac transposase technology. The full announcement is shown ...
Demeetra AgBio has completed the full integration of Hera BioLabs, expanding Demeetra’s rights to the hyperactive Super piggyBac transposase platform ...
LEXINGTON, KY — November 11, 2025 — Demeetra AgBio announced that its flagship CleanCut GS CHO cell line has tested clean on ...
May 12–16, 2025 Hynes Convention Center | Boston, MA We’re bringing our latest innovations in gene editing and cell line ...
May 12-15, 2025 Congress Center Hamburg | Hamburg, Germany We're heading to Hamburg! Demeetra will be on site at BioProcess ...
May 5-8, 2025 San Jose Convention Center - San Jose, CA Demeetra is heading to SynBioBeta 2025, the premier Global ...
April 23-25, 2025San Diego Convention Center - San Diego, CA Demeetra is heading to San Diego for Festival of Biologics ...
LEXINGTON, KY - Demeetra AgBio, a pioneer in precision gene editing technologies for commercially applicable systems, is proud to announce that Hudson ...
Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.
Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.